StockData

TFA Therapeutics, Inc. (RAJAF) stock

RAJAFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026Score 7/30
$9.18+0.00 (0.00%)

Close on Oct 16, 2026Market cap –P/E –Yield –

TFA Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

TFA Therapeutics's total debt was $431.08K at Dec 31, 2023. For fiscal 2023 it was $431.08K, down 8.5% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2023Dec 31, 2023$431.08K-8.5%
FY2022Dec 31, 2022$471.11K+13.8%
FY2021Dec 31, 2021$414.00K0.0%
FY2020Dec 31, 2020$414.00K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2023Dec 31, 2023$431.08K+4.1%
Q3 FY2023Sep 30, 2023$200.38K–
Q4 FY2022Dec 31, 2022$471.11K–
Q4 FY2021Dec 31, 2021$414.00K–
Q4 FY2020Dec 31, 2020$414.00K–

More TFA Therapeutics figures

See a number that looks wrong?